IRF4 and cancer: Starting with a relatively similar distribution of CD45RO+ CD62L+ central memory T cells and CD45RO+ and CD62L- effector memory cells, both CAR T cells with and without IRF4 down-regulation shifted from central memory to effector memory T cells during the consecutive rounds of cancer cell challenge (Figure 3F, Supplementary Figure 3F).